InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank93
3Y CAGR+23.8%
5Y CAGR+21.1%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+23.8%/yr
vs -18.9%/yr prior
5Y CAGR
+21.1%/yr
Consistent
Acceleration
+42.7pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$15.09M+67.9%
2024$8.99M-23.9%
2023$11.81M+48.5%
2022$7.95M-12.7%
2021$9.11M+56.8%
2020$5.81M-40.8%
2019$9.81M-46.6%
2018$18.35M+255.8%
2017$5.16M+12202.3%
2016$41924.00-